Could a single cell therapy tame lupus and other autoimmune diseases?
Disease control
Recruiting now
This early-stage trial tests a new treatment called FT819 for people with certain autoimmune diseases like lupus, vasculitis, myositis, and scleroderma. The treatment aims to target and control the immune cells that cause these diseases. The study will check if FT819 is safe and …
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC